Panossian Vahe S, Berro Moussa M, Ismail Ahmad M, Takkoush Samira I, Chahrour Mohamad A, Fadlallah Yasser A, Bahsoun Aymen A, El Harati Melhem, Jaffa Miran A, Hoballah Jamal J
Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon; Department of Surgery, University of Iowa, Iowa City, IA.
Ann Vasc Surg. 2023 Mar;90:109-118. doi: 10.1016/j.avsg.2022.10.008. Epub 2022 Nov 26.
Thoracic Endovascular Aortic Repair (TEVAR) is a minimally invasive surgery for repairing thoracic aneurysms and dissections. This study aims to compare postoperative outcomes of TEVAR performed under general versus locoregional anesthesia.
Utilizing the 2008-2019 American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, patients older than the age of 18 years who received TEVAR, were identified using the following current procedural terminology codes: 33,880, 33,881, 33,883, 33,884, or 33,886. Patients who underwent concomitant procedures, those with both thoracoabdominal and abdominal aortic pathologies, and trauma cases were excluded. Standard descriptive statistics, in addition to χ, Fisher's exact test, and Mann-Whitney U-tests were used to compare patient baseline characteristics and postoperative outcomes between general and locoregional anesthesia groups as appropriate. Univariable and multivariable logistic regression analyses were performed to assess independent predictors of hospital length of stay (LOS) greater than 7 days.
Of the 1,028 patients included in the study, 86.5% received general anesthesia, and 13.5% received locoregional anesthesia, such as local anesthesia with monitored anesthesia care or regional anesthesia. No significant differences were found between patients receiving locoregional versus general anesthesia in mortality (3.6% vs. 7.9%, respectively, P = 0.071) and morbidity (18.7% and 24.8%, respectively, P = 0.121) within 30 days post-TEVAR, including any wound, pulmonary, thromboembolic, renal, septic, and cardiac arrest complications. Patients who received general anesthesia had significantly higher median LOS compared to those who received locoregional anesthesia [5 days (interquartile range (IQR): 3-10) versus 4 days (IQR: 2-7), P = 0.002], with 34.3% of the general anesthesia group having an LOS greater than 7 days compared to 21.6% of locoregional anesthesia group, P = 0.003. On multivariable logistic regression analysis, general anesthesia was found to be an independent predictor of prolonged LOS greater than 7 days (odds ratio (OR): 1.72, 95% confidence interval (CI): 1.05-2.81, P = 0.031).
Locoregional anesthesia results in significantly lower postoperative hospital LOS with similar postoperative mortality and morbidity compared to general anesthesia in patients undergoing TEVAR.
胸主动脉腔内修复术(TEVAR)是一种用于修复胸主动脉瘤和夹层的微创手术。本研究旨在比较全身麻醉与局部区域麻醉下行TEVAR的术后结果。
利用2008 - 2019年美国外科医师学会国家外科质量改进计划(ACS - NSQIP)数据库,使用以下当前手术操作术语代码识别年龄大于18岁接受TEVAR的患者:33880、33881、33883、33884或33886。排除接受同期手术的患者、患有胸腹主动脉和腹主动脉病变的患者以及创伤病例。除χ检验、Fisher精确检验和Mann - Whitney U检验外,还使用标准描述性统计方法,酌情比较全身麻醉组和局部区域麻醉组患者的基线特征和术后结果。进行单变量和多变量逻辑回归分析,以评估住院时间(LOS)大于7天的独立预测因素。
在纳入研究的1028例患者中,86.5%接受全身麻醉,13.5%接受局部区域麻醉,如监测麻醉下的局部麻醉或区域麻醉。在TEVAR术后30天内,接受局部区域麻醉与全身麻醉的患者在死亡率(分别为3.6%和7.9%,P = 0.071)和发病率(分别为18.7%和24.8%,P = 0.121)方面未发现显著差异,包括任何伤口、肺部、血栓栓塞、肾脏、感染和心脏骤停并发症。与接受局部区域麻醉的患者相比,接受全身麻醉的患者中位LOS显著更高[5天(四分位间距(IQR):3 - 10)对4天(IQR:2 - 7),P = 0.002],全身麻醉组34.3%的患者LOS大于7天,而局部区域麻醉组为21.6%,P = 0.003。在多变量逻辑回归分析中,发现全身麻醉是LOS延长大于7天的独立预测因素(比值比(OR):1.72,95%置信区间(CI):1.05 - 2.81,P = 0.031)。
与全身麻醉相比,局部区域麻醉可使接受TEVAR的患者术后住院LOS显著降低,且术后死亡率和发病率相似。